Application no. and date | 15860676.4 (espacenet) (Federated) (European Patent Register), 20151117 | Patent/reg. no. and date | DK/EP 3220916, 20230419 | Publication date | 20170927 | Priority no. and date | US 201462080985 P, 20141117, US 201562166572 P, 20150526, US 201562251903 P, 20151106 | EP pub. no. and date |
EP 3220916 20170927 | Effective date | | Applicant/owner | Eisai R&D Management Co., Ltd., 6-10, Koishikawa 4-chome Bunkyo-ku
Tokyo 112-8088, JP, Epizyme, Inc., 400 Technology Square, 4th Floor
Cambridge, MA 02139, US | Applicant ref. no. | V2306-010-DK | Inventor | KEILHACK, Heike, 3 Falmouth Street
Belmont, MA 02478, US, TRUITT, Brett, 400 Technology Square 4th Floor
Cambridge, MA 02139, US, SUZUKI, Yuta, 6-10 Koishikawa 4-Chome Bunkyo-ku
Tokyo 112-8088, JP, MURASE, Tsukasa, 6-10 Koishikawa 4-Chome Bunkyo-ku
Tokyo 112-8088, JP, SHIKATA, Futoshi, 6-10 Koishikawa 4-Chome Bunkyo-ku
Tokyo 112-8088, JP | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/5377 (2006.01) , A61K 9/20 (2006.01) , A61P 35/00 (2006.01) | Title | FREMGANGSMÅDE TIL BEHANDLING AF CANCER MED N-((4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL(TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[1,1'-BIPHENYL]-3-CARBOXAMID | Int. application no. | US2015061194 | Int. publication no. | WO2016081523 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|